Share chart Pulse Biosciences, Inc.
Extended chart
Simple chart
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.Main settings
| IPO date | 2016-05-18 |
|---|---|
| ISIN | US74587B1017 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | link |
| Change price per day: | 0% (17.93) |
|---|---|
| Change price per week: | +6.35% (16.86) |
| Change price per month: | +0.7303% (17.8) |
| Change price per 3 month: | -2.24% (18.34) |
| Change price per half year: | -16.21% (21.4) |
| Change price per year: | +48.8% (12.05) |
| Change price per 3 year: | +901.68% (1.79) |
| Change price per 5 year: | +108.49% (8.6) |
| Change price per year to date: | -2.18% (18.33) |
Grade
Underestimation
| Title | Value | Grade |
|---|---|---|
| P/S | -67573.45 | 0 |
| P/BV | 8.85 | 1 |
| P/E | 0 | 0 |
Efficiency
| Title | Value | Grade |
|---|---|---|
| ROA, % | -55.93 | 0 |
| ROE, % | -67.31 | 0 |
| ROIC, % | 0 | 0 |
Dividends
| Title | Value | Grade |
|---|---|---|
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
|---|---|---|
| Debt/EBITDA | -0.1698 | 10 |
| Debt/Ratio | 0.0672 | 10 |
| Debt/Equity | 0.1532 | 10 |
Growth impulse
| Title | Value | Grade |
|---|---|---|
| Yield Revenue, % | -103.64 | 0 |
| Yield Ebitda, % | 6.3 | 1 |
| Yield EPS, % | -57.12 | 0 |
Main owners
| Institutions | Volume | Share, % |
|---|---|---|
| Blackrock Inc. | 1 071 736 | 1.94 |
| Bank of America Corporation | 801 341 | 1.45 |
| Vanguard Group Inc | 657 985 | 1.19 |
| Geode Capital Management, LLC | 379 259 | 0.69 |
| State Street Corporation | 309 520 | 0.56 |
| Griffin Asset Management, Inc. | 259 620 | 0.47 |
| Northern Trust Corporation | 183 665 | 0.33 |
| Spotlight Asset Group, Inc. | 72 090 | 0.13 |
| Bank Of New York Mellon Corporation | 46 129 | 0.08 |
| Morgan Stanley | 45 438 | 0.08 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Robert W. Duggan | Executive Co-Chairman | N/A | 1944 (81 year) |
| Mr. Darrin R. Uecker | CTO & Director | 834.73k | 1966 (59 years) |
| Mr. Mitchell E. Levinson | Chief Strategy Officer | 584.57k | 1960 (65 years) |
| Dr. Richard Nuccitelli Ph.D. | Chief Science Officer | N/A | |
| Mr. Kenneth B. Stratton Esq., J.D. | General Counsel & Corporate Secretary | N/A | 1969 (56 years) |
| Ms. Patty Perla | Vice President of Human Resources | N/A | |
| Mr. David Danitz | Senior Vice President of Engineering | N/A | |
| Mr. Kevin P. Danahy | Chief Commercial Officer | 1971 (54 years) | |
| Mr. Burke T. Barrett | President, CEO & Director | 1964 (61 year) | |
| Mr. Edison Manuel | Vice President of Operations |
About company
Address: United States, Hayward. CA, 3957 Point Eden Way - Open in google maps, Open in yandex maps
Website: https://www.pulsebiosciences.com
Website: https://www.pulsebiosciences.com
